|
Catalog Number 306572 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Fever (1858); Nausea (1970)
|
Event Date 01/09/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Multiple lot numbers: there were multiple lot numbers reported to be involved.The information for each lot number is as follows: medical device lot #: 8242797.Medical device expiration date: 2021-08-31.Device manufacture date: 2018-08-30.Medical device lot #: 8270683.Medical device expiration date: 2021-08-31.Device manufacture date: 2018-09-27.(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that after using bd posiflush¿ xs pre-filled flush syringe, patient experienced symptoms of nausea, slight increase in body temperature.There was unknown cause of pyrexia.Patient was advice to go to hospital.Customer¿s verbatim: ¿ we have received an adverse event report on (b)(6) 2019 concerning the aforementioned product, whereby patient experienced symptoms of nausea and slight increase in body temperature - no known cause for pyrexia.Patient advised to attend hospital; no further information has been obtained in regards to patient outcome following a& e visit.Product - 306572 pfs 0.9% p/flush xs saline.Batch - 8242797 / 8270683.Samples: no use: 10 ml to flush line before and 20 ml after each infusion as directed.¿.
|
|
Manufacturer Narrative
|
Investigation summary: dhr: the non-conformances were reviewed for these batches, and there was no record of non-conformance which could contribute to the complaint verbatim reported by the customer.There is no evidence that posiflush syringe was responsible for this reaction.A potential contributory factor maybe other medicinal products in use or administered at the time the patient¿s port was flushed.Conclusion(s): based on the information provided, it is more probable than not that the symptoms described may be an allergic reaction; however, it is highly improbable that this reaction was produced by the normal saline in the bd posiflush product.During the period 2017-2019, there are no other adverse customer complaint trends for the complaint category of allergic reaction, apart from fresenius kabi uk.There are no known allergies to normal saline, either topical or within the body.It is most likely that whatever fluid was in the iv line prior to flushing contained inadequately flushed medication or glucose from previous treatments.
|
|
Event Description
|
It was reported that after using bd posiflush¿ xs pre-filled flush syringe, patient experienced symptoms of nausea, slight increase in body temperature.There was unknown cause of pyrexia.Patient was advice to go to hospital.Customer¿s verbatim: ¿ we have received an adverse event report on (b)(6) 2019 concerning the aforementioned product, whereby patient experienced symptoms of nausea and slight increase in body temperature - no known cause for pyrexia.Patient advised to attend hospital; no further information has been obtained in regards to patient outcome following a& e visit.Product - 306572 pfs 0.9% p/flush xs saline.Batch - 8242797 / 8270683.Samples: no use: 10 ml to flush line before and 20 ml after each infusion as directed.¿.
|
|
Search Alerts/Recalls
|
|
|